Quality of life improves in vasovagal syncope patients after clinical trial enrollment regardless of fainting in follow-up
- 1 July 2019
- journal article
- research article
- Published by Elsevier BV in Autonomic Neuroscience
- Vol. 219, 42-48
- https://doi.org/10.1016/j.autneu.2019.04.001
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (MOP142426)
- Cardiac Arrhythmia Network of Canada (SRG-15-P01-001, SRG-17-P27-001)
- Vanderbilt Institute for Clinical and Translational Research (NIH UL1-TR000445)
This publication has 14 references indexed in Scilit:
- Clinical improvement of vasovagal syncope in the absence of specific therapies: The Seinfeld effectCardiology Journal, 2014
- Quality of Life Within One Year Following Presentation After Transient Loss of ConsciousnessThe American Journal of Cardiology, 2007
- Vasovagal syncope in medical students and their first-degree relativesEuropean Heart Journal, 2006
- The Second Prevention of Syncope Trial (POST II)—a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: Rationale and study designAmerican Heart Journal, 2006
- Clinical Factors Associated with Quality of Life in Patients with Transient Loss of ConsciousnessJournal of Cardiovascular Electrophysiology, 2006
- Short-term evolution of vasovagal syncope: Influence on the quality of lifeInternational Journal of Cardiology, 2005
- Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design.EP Europace, 2003
- The RAND-36 measure of health-related quality of lifeAnnals of Medicine, 2001
- The rand 36‐item health survey 1.0Health Economics, 1993
- Impairment of physical and psychosocial function in recurrent syncopeJournal of Clinical Epidemiology, 1991